Wednesday, October 7, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 5, 2026

Wells Fargo Stock Jumps Nearly 19% in 3 Months: Right Time to Buy?

View original at finance.yahoo.com
Wells Fargo Stock Jumps Nearly 19% in 3 Months: Right Time to Buy? Shares of Wells Fargo & Company WFC have gained 18.6% in the past three months compared with the industry’s rise of 9.1%…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Wells Fargo expects 2025 NII to be in line with 2024 NII of $47.7 billion

    80% confidence

  • Wells Fargo signaled workforce could shrink in 2026 as part of push to improve efficiency and incorporate AI

    80% confidence

  • Wells Fargo carries Zacks Rank #2 (Buy)

    80% confidence

  • Wells Fargo stock worth investing in now for solid long-term returns

    80% confidence

  • Wells Fargo expects to achieve $15 billion in gross expense savings by end of 2025

    80% confidence

  • Zacks Consensus Estimate for WFC 2025 sales suggests 2.1% growth

    80% confidence

  • Wells Fargo targets up to $10 billion in annual cost cuts

    80% confidence

  • Zacks Consensus Estimate for WFC 2026 sales suggests 5.4% growth

    80% confidence

  • Zacks Consensus Estimate for WFC 2026 earnings indicates 11.7% rally

    80% confidence

  • Wells Fargo raised medium-term ROTCE target to 17-18% from earlier 15%

    80% confidence

  • Management characterized AI transition as a 'positive reality' suggesting AI-enabled efficiencies will support long-term operational improvements

    80% confidence

  • Zacks Consensus Estimate for WFC 2025 earnings indicates 16.9% rally

    80% confidence

  • Wells Fargo plans to introduce AI gradually over next year and continue expanding use beyond 2026

    80% confidence

  • By end of 2025, slightly more than half of branch network expected to be refreshed

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,351 source documents archived
Query this data → isubstrate.com
Wells Fargo Stock Jumps Nearly 19% in 3 Months: Right Time to Buy? — Source | Via News | ViaNews Market